BA6b9, a novel sk4 K + channel blocker, attenuates atrial fibrillation substrate in rats with reduced ejection fraction

1 September 2024 (10:00 - 10:50)

Organised by:

Video

Abstract

Sign in to view the resources

Slides

About the speaker

Mr Or Levi

Ben-Gurion University of the Negev, Beer Sheva (Israel)

8 More presentations in this session

Presentation thumbnail

Efficacy and safety of ultrasound guided stellate ganglion block: developing new clinical indications beyond electrical storm

Doctor A. Morena (Pavia, IT)

Abstract Slides Video

Presentation thumbnail

Atrial and ventricular arrhythmias in young, lifelong and retired elite endurance athletes

Doctor P. D'Ambrosio (Fitzroy, AU)

Abstract Slides Video

Presentation thumbnail

Analysis of safety and outcome of use of NOAC in intracardiac thrombi over warfarin

Doctor O. Al-assaf (Dubai, AE)

Abstract Slides Video

Presentation thumbnail

Amiodarone-related thyroid dysfunction and associated outcomes in patients with heart failure - a matched case-control study

Doctor S. Ali (Copenhagen, DK)

Abstract Slides Video

Presentation thumbnail

Association between preprocedural thromboembolic or bleeding events under oral anticoagulation therapy and mid-term outcomes after percutaneous left atrial appendage closure

Doctor H. Sumiyoshi (Kamogawa, JP)

Abstract Slides Video

Access the full session

Session thumbnail

Clinical and experimental arrhythmia treatments

The Event

Event poster

ESC Congress 2024

1 September 2024 10:00 CET

You may be interested in

Congress Presentation

Head to head comparison of semaglutide and colchicine for treating atrial remodeling in post-MI rats with reduced ejection fraction

Congress Session

Molecular and cellular drivers of arrhythmia

Congress Presentation

Promising electrical targets for novel antiarrhythmic strategies in atrial fibrillation

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources